PRDM9 and pulmonary fibrosis: Collectively, these data demonstrate that histone methyltransferase DOT1L is a novel epigenetic driver in pulmonary fibrosis, while blockade of DOT1L effectively decreases the pulmonary fibrosis phenotypes.